Acute External Ventricular Drain Market (2026 - 2033) Size, Share & Trends Analysis Report By Application (Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage), By Patient Type (Pediatric, Adult), By Region, And Segment Forecasts

Acute External Ventricular Drain Market Summary

In addition, expanding neurosurgical infrastructure, greater availability of advanced drainage and monitoring systems, rising road traffic injuries, and increasing government investments in trauma and brain injury management programs are further supporting global market expansion.

Acquired Brain Injury (ABI) is a major clinical factor driving demand for acute external ventricular drains. Many ABI conditions lead to elevated intracranial pressure (ICP), hydrocephalus, or cerebrospinal fluid (CSF) accumulation, all of which require immediate pressure monitoring and fluid drainage. Conditions such as traumatic brain injury, stroke, brain tumors, and intracranial hemorrhage frequently result in acute neurological deterioration, requiring rapid neurosurgical intervention in intensive care settings. According to the World Health Organization, brain injuries and stroke remain leading causes of disability and mortality globally, increasing the need for critical neuro-monitoring devices. As hospital admissions for ABI rise due to aging populations, increasing road accidents, sports injuries, and better diagnostic detection, the need for emergency neurosurgical procedures also increases. Acute EVD systems are essential in these scenarios because they allow real-time ICP monitoring while simultaneously draining excess CSF, helping prevent secondary brain damage.

Key Acquired Brain Injury (ABI) and Related Hospital Admission Statistics - UK (2023-2024)

Source: Headway - the brain injury association

Road accidents significantly drive the acute EVD market. Severe road trauma is one of the leading causes of traumatic brain injury, which results in increased intracranial pressure, intracranial bleeding, and cerebrospinal fluid accumulation requiring urgent neurosurgical intervention. AS per the WHO, approximately 1.19 million people die each year as a result of road traffic crashes. Road traffic injuries are the leading cause of death for children and young adults aged 5-29 years. High-impact collisions frequently lead to skull fractures, diffuse axonal injury, and intracranial hemorrhage, all of which may require external ventricular drainage for pressure management and neurological stabilization. In addition, increasing vehicle density, urbanization, and rising two-wheeler use in developing regions are contributing to higher accident rates, thereby increasing emergency neurosurgical admissions. Improvements in trauma response systems and increased availability of neurocritical care units are also leading to higher diagnosis and treatment rates of severe brain injuries, further supporting demand for acute EVD systems worldwide. As per the WHO, approximately 1.19 million people die each year as a result of road traffic crashes. Road traffic injuries are the leading cause of death for children and young adults aged 5-29 years.

Monthly Road Fatality Key Statistics - Australia (December 2025 Update)

Source: Commonwealth of Australia

Government initiatives focused on traumatic brain injury are significantly driving the acute external ventricular drain industry by strengthening neurotrauma care infrastructure, improving early diagnosis rates, and expanding access to advanced neurosurgical treatment. Public health agencies such as the World Health Organization and national bodies such as the Centers for Disease Control and Prevention actively promote TBI surveillance, prevention strategies, and standardized treatment protocols, thereby increasing the detection and hospital admissions of severe brain injury cases.

Many governments are also investing in trauma center expansion, emergency response modernization, and the development of neurocritical care units, ensuring that more patients receive timely intracranial pressure monitoring and cerebrospinal fluid management. In addition, national brain health programs and trauma registries improve clinical awareness of secondary brain injury risks, encouraging earlier adoption of EVD placement in intensive care settings. Increased public funding for neurotrauma research and hospital infrastructure further supports the adoption of advanced neurosurgical devices, strengthening the demand for acute EVD systems across developed and emerging healthcare markets.

Government Initiatives for Traumatic Brain Injury (TBI) 

Source: GVR Analysis, CDC, NMPA, FDA

Market Concentration & Characteristics

The degree of innovation in the industry is moderate, driven by ongoing advancements in neurosurgical technologies and patient-safety features. Manufacturers are focusing on developing antimicrobial-impregnated catheters to reduce infection risk, pressure monitoring-integrated EVD systems for real-time intracranial pressure tracking, and closed drainage systems to improve sterility and handling. In addition, improvements in catheter materials, imaging-guided placement techniques, and digital monitoring solutions are enhancing clinical outcomes and procedural efficiency.

For instance, in March 2025, Anuncia Medical, Inc. received FDA Breakthrough Device Designation for its ReFlow EVD, an innovative solution designed to improve the performance of external ventricular drains in managing elevated intracranial pressure. This milestone builds on the success of its ReFlow portfolio and strengthens the company’s position in advancing acute and long-term CSF management within neurocritical care.

The level of mergers and acquisitions activity in the industry is moderate, with transactions primarily aimed at expanding neurosurgical product portfolios, strengthening regional presence, and gaining access to advanced catheter and monitoring technologies. Large medical device companies are actively acquiring smaller, specialized firms to enhance innovation capabilities and accelerate product development timelines. In addition, strategic partnerships and distribution agreements are common, particularly to improve market penetration in emerging regions. As demand for advanced neurocritical care solutions continues to rise, M&A activity is expected to remain stable, driven by technology integration and competitive positioning strategies.

Regulations play a critical role in shaping the industry by influencing product development, approval timelines, manufacturing standards, and post-market surveillance requirements. Regulatory frameworks ensure device safety, sterility, biocompatibility, and clinical effectiveness, particularly for neurosurgical devices used in critical care settings. In the U.S., approvals and compliance are governed by the U.S. FDA, which requires stringent clinical and quality documentation. In Europe, the transition to stricter device requirements under the oversight of the European Medicines Agency and MDR frameworks has increased compliance costs but improved product safety standards. In Asia, regulatory pathways are evolving, with agencies such as the National Medical Products Administration and the Central Drugs Standard Control Organization strengthening approval and monitoring processes.

Application Insights

Traumatic brain injury dominated the market in 2025, due to the high incidence of road traffic accidents, falls, sports injuries, and violence-related head trauma across both developed and developing regions. TBI frequently leads to elevated intracranial pressure and hydrocephalus, requiring immediate cerebrospinal fluid diversion, thereby increasing demand for acute external ventricular drainage procedures. In addition, the growing emergency care infrastructure, rising awareness of early neurosurgical intervention, and improved access to trauma centers are further contributing to segment dominance. The increasing global burden of trauma cases, particularly in urbanizing and high-population regions, is expected to sustain strong procedural demand for acute EVD use in traumatic brain injury management.

Intracerebral hemorrhage is expected to grow at a significant CAGR globally, primarily driven by the rising number of cases linked to population aging, increasing prevalence of hypertension, diabetes, and other chronic vascular disorders. The global burden continues to rise despite improvements in mortality rates, as total incidence and prevalence increase due to demographic expansion and longer life expectancy. In addition, higher disease burden in low- and middle-income countries, rising lifestyle risk factors, and improved diagnostic access are expected to support demand for procedures. Since intracerebral hemorrhage is a significant cause of stroke-related mortality and disability worldwide, the growing clinical burden is expected to drive sustained demand for acute neurocritical care interventions, including external ventricular drainage.

Patient Insights

Adult patients dominated the acute EVD market in 2025 due to the higher global burden of neurological disorders requiring intracranial pressure management and cerebrospinal fluid drainage. Conditions such as traumatic brain injury, intracerebral hemorrhage, subarachnoid hemorrhage, and hydrocephalus are more frequently diagnosed in adult and aging populations worldwide, leading to higher ICU admissions and neurosurgical interventions. Rising incidence of stroke, increasing road traffic accidents, growing elderly population, and improved access to neurocritical care services across developing and developed regions have collectively driven procedure volumes. In addition, clinical management approaches aligned with WHO guidance have supported early diagnosis and monitoring of neurological emergencies, further strengthening adult patients' contribution to the global acute EVD market in 2025.

The pediatric patient segment is expected to grow at a significant CAGR over the forecast period, driven by increasing diagnoses of congenital neurological disorders, rising incidence of pediatric hydrocephalus and neonatal intraventricular hemorrhage, and growing awareness of early neurosurgical intervention in infants and children. Improvements in neonatal intensive care infrastructure, expansion of pediatric neurosurgery capabilities in emerging economies, and increasing survival rates among preterm infants are further driving demand for acute EVD procedures. In addition, ongoing technological advancements in smaller, more precise drainage systems designed specifically for pediatric anatomy are expected to support segment growth globally.

Regional Insights

North America dominated the acute external ventricular drain market with the revenue share of 35.23% in 2025, driven primarily by the rising incidence of traumatic brain injuries, stroke, and hydrocephalus across the region. Advanced healthcare infrastructure, high neurosurgical procedure volumes, and strong adoption of technologically advanced drainage and monitoring systems are supporting market expansion. The U.S. dominates regional revenue due to higher healthcare spending, favorable reimbursement frameworks, and the strong presence of leading medical device manufacturers, while Canada is showing gradual growth, supported by improved access to neurosurgical care and increasing awareness of early intracranial pressure management. In addition, continuous product innovations, infection-control-focused EVD designs, and the growing demand for minimally invasive neurosurgical procedures are expected to further accelerate market growth over the forecast period.

U.S. Acute External Ventricular Drain Market Trends

The acute external ventricular drain market in the U.S. is experiencing growth, primarily driven by the rising burden of neurological conditions and increasing adoption of advanced neurosurgical technologies. Demand is expanding due to the high incidence of traumatic brain injuries, strokes, aneurysms, and hydrocephalus, along with a rapidly aging population that requires more neurosurgical interventions. In addition, increasing cases of road accidents, sports injuries, and critical care admissions are supporting procedure volumes, thereby directly increasing EVD utilization. The market is also benefiting from the introduction of technologically advanced drainage systems and a growing preference for minimally invasive neurosurgical approaches that improve patient outcomes and reduce recovery time.

According to the U.S. Department of Transportation and the National Highway Traffic Safety Administration, traffic fatalities for the first half of 2025 are estimated at approximately 17,140 deaths from motor vehicle crashes. Preliminary data show that vehicle miles travel increased by about 12.1 billion miles, representing a 0.8% increase.

Europe Acute External Ventricular Drain Market Trends

The acute external ventricular drain market in Europe is growing, driven by the rising burden of neurological emergencies such as traumatic brain injury, stroke, and intracranial hemorrhage, which require immediate cerebrospinal fluid drainage in neuro-ICU settings. The increasing elderly population and higher incidence of neurodegenerative and vascular brain conditions are also contributing to procedure volumes. The region benefits from well-established neurosurgical infrastructure, strong hospital networks, and high adoption of advanced critical care technologies. In addition, strict infection-prevention standards are encouraging the shift toward antimicrobial-coated catheters and single-use drainage kits. Major healthcare systems in countries such as Germany, France, and the UK continue to support market growth through strong reimbursement frameworks, neurosurgical training programs, and early adoption of advanced neurocritical care devices.

The UK acute external ventricular drain market is driven by the country’s strong neurocritical care infrastructure and rising neurological disease burden. Demand is driven by a high incidence of traumatic brain injuries, stroke, subarachnoid hemorrhage, and hydrocephalus, all of which require intracranial pressure management using external ventricular drain(EVD) systems in emergency and ICU settings. According to the European Journal of Cardiovascular Medicine, every year, more than 10 million people are affected by traumatic brain injuries. In addition, the UK benefits from a well-established critical care network and advanced neurosurgical capabilities, which support consistent utilization of ventricular drainage devices in both trauma and elective neurosurgical procedures.

The acute external ventricular drain market in Germany is supported by the country’s strong neurosurgical infrastructure, aging population, and rising neurological disease burden. Germany benefits from Europe’s well-established public healthcare system and standardized neurosurgical protocols, which have helped expand adoption of advanced EVD systems and improve hospital access to neurocritical care technologies. Across Europe, rising use of infection-resistant and closed EVD systems, along with stronger procurement programs in public hospitals, is improving device availability and clinical uptake.

The German Brain Plan: Agenda 2030 supports the German acute neuro care and neuro device ecosystem primarily through policy, research funding, clinical translation, and strengthening the innovation ecosystem. The German Brain Plan (launched by the German Brain Council) is a national roadmap focused on improving brain health, prevention, treatment, and the translation of research across the full lifespan. It emphasizes that brain health is critical to overall health, national productivity, and innovation competitiveness, which drives long-term investment and healthcare prioritization.

Asia Pacific Acute External Ventricular Drain Market Trends

The acute external ventricular drain market in the Asia Pacific is supported by structural healthcare improvements and rising neurocritical care demand across major countries. Rapid expansion of neurosurgical capacity, growth in tertiary care hospitals, and strong local manufacturing ecosystems are enabling both global and regional device companies to penetrate the market more effectively. Evolving regulatory frameworks across Asia are improving device approvals and market-entry pathways, though price sensitivity remains in some emerging countries.

Factors supporting the acute external ventricular drain market in China are mainly driven by the rapid expansion of healthcare infrastructure, the rising neurological disease burden, and substantial government healthcare investment. The increasing incidence of traumatic brain injury, stroke, intracranial hemorrhage, and hydrocephalus is driving demand for emergency neuro-ICU procedures requiring ventricular drainage. At the same time, China is significantly expanding tertiary hospitals, trauma centers, and neurosurgical capabilities, improving access to advanced neurocritical care. Growth is further supported by strong domestic medical device manufacturing, which is enhancing the availability of cost-effective EVD systems across public hospitals. In addition, government healthcare reforms, increasing insurance coverage, and rising healthcare spending are enabling wider adoption of advanced neurosurgical devices. Increasing physician training programs and technology transfer from global medtech companies are also strengthening clinical adoption of modern ventricular drainage systems across major urban hospitals.

The Healthy China 2030 initiative strongly supports the acute external ventricular drain market in China by driving large-scale modernization of the healthcare system, expanding access to advanced treatments, and accelerating the adoption of medical technologies. The policy is a long-term national strategy focused on improving population health, expanding healthcare services, strengthening health security, and developing the healthcare industry, which indirectly increases demand for advanced neurosurgical and critical care devices.

The India acute EVD market is growing, supported by expansion in neurosurgical care capacity, rising neurological disease burden, and healthcare system modernization. Increasing cases of traumatic brain injury, hemorrhagic stroke, hydrocephalus, and neuro-ICU admissions are driving demand for temporary cerebrospinal fluid drainage and intracranial pressure monitoring devices such as acute EVD systems. Alongside this, the expansion of tertiary hospitals, trauma centers, and neurology specialty institutes across major metro and Tier-2 cities is improving procedural volumes and device adoption.

Middle East Africa Acute External Ventricular Drain Market Trends

The acute external ventricular drain market in the Middle East and Africa is supported by improving healthcare infrastructure, increasing trauma and neurological disease burden, and rising government healthcare investments. Demand is primarily driven by growing cases of traumatic brain injury, stroke, and intracranial hemorrhage, particularly in rapidly urbanizing regions. Countries such as Saudi Arabia and the UAE are investing heavily in advanced hospital infrastructure, trauma centers, and neurocritical care capacity, which is improving the adoption of advanced neurosurgical devices. In Africa, countries like South Africa are leading in terms of neurosurgical capability and private healthcare investment, supporting procedural growth. In addition, rising medical tourism in parts of the Middle East, increasing physician training, and the gradual expansion of tertiary care hospitals are improving access to advanced neuro-ICU technologies.

Key Acute External Ventricular Drain Companies Insights

Companies are adopting several strategies such as collaborations, launching new products, and increasing their geographic footprint and distribution network by adopting the following strategic initiatives to gain a higher market share.

Recent Development

• In September 2025, B. Braun announced a manufacturing expansion in the Lehigh Valley, highlighting the region’s strong business environment as a key factor enabling the company to compete and succeed globally. The expansion is part of B. Braun’s broader commitment to enhancing production capabilities and supporting long-term growth in advanced medical technologies.

• In January 2025, Integra LifeSciences Holding Corporation, a global provider of medical technology, announced the launch of the Integra Institute, its new global medical education platform. This digital initiative is designed to strengthen the company’s medical education programs across surgical, neurologic, ENT, and regenerative care specialties by providing healthcare professionals with comprehensive, on-demand learning resources to support ongoing professional development.

• In May 2024, Medtronic Neurosurgery announced a recall of the Duet External Drainage and Monitoring System due to a risk that the catheter tubing could disconnect from the patient line stopcock connectors. The recall was issued to address this potential safety concern and prevent possible complications associated with unintended disconnection.

• In July 2023, Integra LifeSciences announced favorable clinical and economic outcomes for the Codman Bactiseal External Ventricular Drain (EVD) catheter set in treating hydrocephalus, a complication arising from aneurysmal subarachnoid hemorrhage (aSAH).

Acute External Ventricular Drain Market Report Scope

Global Acute External Ventricular Drain Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global acute external ventricular drain market report based on application, patient type, and region: 

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Traumatic Brain Injury

  • Subarachnoid Hemorrhage

  • Intracerebral Hemorrhage

  • Other Non-traumatic Hydrocephalus Conditions

• Patient Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Pediatric

  • Adult

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait